Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STANDUP AHF: Cimlanod in Acute Heart Failure
NCT03016325Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of cimlanod in heart failure (HF), sponsored by Bristol Myers Squibb. Started Jan 2017; status: completed.
02
Drugs
cimlanod
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03016325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03016325.